What should I do if I need surgery for prostatic hyperplasia or prostate cancer, but my physical condition cannot withstand surgery?Recently, Guangzhou United Family Hospital and Clinics completed the first transrectal ultra-minimally invasive AI-HIFU prostate surgery in South China, which is non-incisive, bloodless, non-invasive, and accurate at the "millimeter" level, which ensures the efficacy and protects the prostate's urinary continence function and sexual function, marking the "non-invasive" era of prostate diseases.
Give patients who are unable (willing) to undergo surgery a chance at "surgery".
80-year-old Mr. Gao suffered from dysuria due to prostatic hyperplasia, and in the past month, he even needed to urinate with the help of a urinary catheter, and his quality of life has deteriorated dramatically, and his dignity has been challenged. Medication** could not solve the problem, and surgery was imminent, but considering that Mr. Gao had high blood pressure, bronchiectasis, and Parkinson's disease, the family did not dare to take the risk. As a result, the team of experts at Guangzhou United Family Hospital and Clinics customized an ultra-minimally invasive surgical plan for him, AI-HIFU.
After we place the ultrasound probe through the patient's rectum, the screen of the machine clearly shows the hyperplasia of the prostate tissue and urethra, and then the probe emits ultrasound energy, and the intraoperative 'real-time image' tracks, the hyperplasia of the prostate tissue is slowly ablated in silence, and the operation process is no incision, no blood, and no invasiveness. Yang Weiqing, director of the Department of Urology at Guangzhou United Family Hospital, said that the AI-HIFU technology gives more opportunities for prostate cancer and prostatic hyperplasia patients who are not in ideal physical condition, have poor tolerance to surgery, or are unwilling to undergo surgery.
Millimeter-level accuracy to maintain urinary control and sexual function.
Another "early adopter" Mr. Lin is an advanced prostate cancer patient, who hopes to further control the development of the tumor through AI-HIFU technology while taking the first step of the drug, "while cutting the tumor as clean as possible, without damaging urinary continence and sexual function", this is the voice of the vast majority of prostate cancer patients, including Mr. Lin. "With the AI-HIFU technology, the ablation area can be precisely planned with millimeter accuracy, killing cancer cells while avoiding damage to the urethral sphincter and the sexual nerves around the prostate. Director Yang Weiqing introduced. In the end, Mr. Lin's urinary continence and sexual function were not affected by the surgery, and he only needed to continue endocrinology**.
Director Yang Weiqing said that compared with surgery, AI-HIFU surgery not only avoids the risk of pain, infection and bleeding of surgery, but also has the conditions to fully protect the patient's urinary continence and sexual function, ensuring that the efficacy greatly improves the experience and quality of life of patients with prostate cancer and prostatic hyperplasia.
Prostate disease** has entered the era of "non-invasive".
It is understood that Sonablate AI-HIFU is the world's first device to enter the body through the rectum for prostate tumors, and it is also the only cancer ultrasound technology that has passed the certification of the EU CE, THE U.S. FDA, and the State Food and Drug Administration of China. Although this new technology has just entered the country, it has already been widely recognized in the world, and many publications such as "European Urology" have confirmed its excellent efficacy on urological diseases.
Guangzhou United Family Hospital and Clinics (Guangzhou United Family Hospital) is the first hospital in the province to introduce this cutting-edge innovative technology and establish a minimally invasive prostate center, marking the beginning of the "non-invasive" era of prostate diseases** in the hospital. "This is not only another breakthrough in the field of medical technology innovation, but also heralds the arrival of a more humane and precise medical era, opening a healthier and better quality future for patients with prostate diseases. Kelly Xia, President of Guangzhou United Family Hospital, said that in the future, the hospital will provide patients with a comprehensive diagnosis and treatment plan from open surgery to minimally invasive** to non-invasive diagnosis and treatment, so as to help more patients with prostatic hyperplasia and prostate cancer get rid of the disease and have a healthy life. It is understood that in the future, Shenzhen United Family Hospital will also carry out related surgeries to benefit more patients in the Greater Bay Area.
On December 21, UFH and Sonablate signed a strategic cooperation framework agreement to cooperate in various fields, including urological diseases. Since the invention of the first ultrasound cancer device in human history, after decades of continuous innovation and improvement and the accumulation of clinical application data around the world, SonaBlate has achieved a technological leap in non-invasive tumor surgery without relying on other imaging equipment, "artificial intelligence automation, intraoperative 'real-time image' tracking, accurate and non-invasive, gland preservation focus**" It has become a technical label for the company's products based on global medical theory innovation and clinical practice testing.
The free clinic is coming!In order to promote early screening, early diagnosis and early treatment of prostate diseases, the Center for Prostate Ultravasive** at Guangzhou United Family Hospital and Clinics will provide free medical services for patients with prostatic hyperplasia and prostate cancer from now until June 2024. Interested patients (men over 50 years old) can call Guangzhou United Family Hospital's 24-hour service**4008919191 to make an appointment, including a free urologist consultation (40 minutes).
Text|Reporter Chen Huitu|The hospital provides.